Therapeutic Asset Ratings
7,018 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vinorelbine
Aggressive Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
Vinorelbine
Lung Large Cell Carcinoma
AIO-Studien-gGmbH
P3
BB
(70)
Xzp-3621
Non-Small Cell Lung Carcinoma
Xuanzhu Biopharmaceutical Co., Ltd.
P3
BB
(70)
Zipalertinib
Non-Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer Center
P3
BB
(70)
Zofran
Chronic Lymphocytic Leucemia
Mayo Clinic
P3
BB
(70)
Zongertinib
Non-Small Cell Lung Carcinoma
Boehringer Ingelheim
P3
BB
(70)
4,5,7,4',5',7'-HEXAHYDROXY-2,2'-DIMETHYLNAPHTHODIANTHRONE
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Soligenix
P3
BB
(69)
Acetylsalicylic Acid
Breast Carcinoma
Mayo Clinic
P3
BB
(69)
Acetylsalicylic Acid
Lynch Syndrome
M.D. Anderson Cancer Center
P3
BB
(69)
ARG
Sickle Cell Disease
Tanta University
P3
BB
(69)
Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA) introduced transiently as ribonucleoprotein (RNP) complex, targeting the erythroid lineage-specific enhancer region of BCL11A (B-cell lymphoma/leukemia 11A). The site-specific cleavage by Cas9 forms a double strand break (DSB), which is subsequently repaired by nonhomologous end-joining (NHEJ), leading to the transcriptional repression of BCL11A, a repressor of ?-globin gene transcription
Disease Of Genetic Or Genomic Mechanism
Vertex Pharmaceuticals Incorporated
P3
BB
(69)
Axitinib
Kidney Neoplasm
Pfizer
P3
BB
(69)
Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)-
Lennox-Gastaut Syndrome
University of Chicago
P3
BB
(69)
Calcium folinate pentahydrate
Acute Lymphoblastic Leukemia
Andrew E. Place, MD
P3
BB
(69)
Calcium folinate pentahydrate
B Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(69)
Calcium folinate pentahydrate
Colon Cancer
Akeso
P3
BB
(69)
Calcium folinate pentahydrate
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
P3
BB
(69)
Calcium folinate pentahydrate
Metastatic Cancer
I-Mab Biopharma US Limited
P3
BB
(69)
Calcium folinate pentahydrate
Metastatic Malignant Neoplasm in the Peritoneum
City of Hope Medical Center
P3
BB
(69)
Calcium folinate pentahydrate
Rectal Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(69)
Capecitabine
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US Limited
P3
BB
(69)
Capecitabine
Metastatic Neoplasm
University of Southern California
P3
BB
(69)
Carboplatin
Adenosquamous Lung Carcinoma
NRG Oncology
P3
BB
(69)
Casodex
Prostate Adenocarcinoma
OHSU Knight Cancer Institute
P3
BB
(69)
cc-5013
B-Cell Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer Centre
P3
BB
(69)
Showing 626 to 650 of 7,018 assets
Previous
Page 26 of 281
Next